middle.news
How Osteopore’s Swiss Approval and Zimmer Biomet Deal Spark 3x Sales Growth
9:38am on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
How Osteopore’s Swiss Approval and Zimmer Biomet Deal Spark 3x Sales Growth
9:38am on Friday 31st of October, 2025 AEDT
Key Points
Q3 CY25 revenue of AUD 812K, up 7% YoY
Swiss market approval under EU MDR for custom orthopaedic and cranial implants
Zimmer Biomet partnership drives 3x implant sales growth in EMEA and APAC
Wins two public hospital tenders in Vietnam for orthopaedic products
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
OSTEOPORE (ASX:OSX)
OPEN ARTICLE